1.
Müller B, Curatolo R, Juratli H, Husic A, Nehring J, Potlukova E, et al. Severe cutaneous toxicity in a 67-year-old patient with metastatic urothelial carcinoma undergoing therapy with enfortumab vedotin and pembrolizumab. EJCRIM [Internet]. 2024 Nov. 28 [cited 2026 Nov. 18];11(12). Available from: https://ojs.wedare.app/ejcrim/article/view/5003